Aiming to Boost Molecular Dx Portfolio, Cepheid Acquires Assay Maker Sangtec | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
In an effort to expand its emerging molecular diagnostics business, Cepheid announced last week that it has acquired Sangtec Molecular Diagnostics from Altana Pharma for approximately $27 million in cash.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.